Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 34 brain cancer PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


brain cancer PhD Projects, Programmes & Scholarships

We have 34 brain cancer PhD Projects, Programmes & Scholarships

Peptide-based nanoparticles for brain targeted gene delivery.

Gene therapy has the potential to provide therapeutic benefit to millions of people with neurodegenerative diseases and cancer. Delivery into the brain is hampered by the blood-brain barrier (BBB), which limits the efficacy of both conventional and novel therapies at the target site. Read more

(MRC DTP CASE) Multiomic evaluation of differential drug response in metastatic breast cancers

Breast cancers are the most common cancers in women. Estrogen Receptor (ER) plays a major role in breast cancer growth. To stop the cancer from growing further, clinically successful ER-targeting therapies like Fulvestrant, etc were developed. Read more

New Drugs for Brain Tumours: Prodrugs of Diazopropyne

  Research Group: Medicines Development and Pharmaceutical Sciences
The propargyl group, introduced to temozolomide-like drugs for brain tumours by our colleagues in Nottingham, shows considerable pre-clinical promise and… Read more

The role of GLUT transporters in microglial metabolism, investigating functionality, regulation and drug targetable properties.

Modifying the brain’s metabolism as an intervention or for the treatment of Alzheimer’s disease represents a novel strategy for targeting what is recognised as a multifactorial condition which lacks effective therapeutic options.   . Read more
Last chance to apply

Developing virtual reality for paediatric neurorehabilitation

Brain and spinal cord tumours are the second most common types of cancer in children and young people (CYP) after leukaemia, accounting for approximately 1 out of every 4 childhood cancers. Read more

Investigation of the extracellular matrix as a regulator of Parkinson’s progression

  Research Group: Chemistry and Biosciences
Parkinson’s is the 2nd most common neurodegenerative disease, affecting around 1 in 20 people aged over 65. In the UK, the number of affected people is set to rise by 50% over the next 50 years due to ageing populations. Read more

(MRC DTP CASE) Understanding how tumour associated macrophages control the tumour immune landscape in NF2-Schwannomatosis

Type 2 Neurofibromatosis (NF2), now referred to as NF2-Schwannomatosis (or NF2-SWN), is a rare autosomal dominant tumour pre-disposition syndrome characterised by growth of typically benign tumours throughout the nervous system. Read more
Last chance to apply

Early detection of neurodegenerative disorders using artificial intelligence

A fantastic opportunity for a PhD student to complete an exciting project which aims to utilize vision deep learning for early detection of neurodegenerative disorders. Read more

Characterisation of tissue microstructure from non-invasive MRI using Machine Learning

The characterisation of biological tissue microstructure in vivo and non-invasively is of outmost interest in science. If successful, it could reveal unique insights into biological processes, including aging and cancer. Read more

17 Graduate Teaching Assistants (GTAs) in the Institute of Industry and Innovation

The Institute of Industry and Innovation (I2RI) at Sheffield Hallam University intends to appoint up to 17 GTAs on 3.5 year fixed-term, full-time studentships from October 2024, with annual stipend at the living wage foundation rate (currently £19,722 in the academic year 23/24). Read more

Filtering Results